Clinical trial
Comparison of the Clinical Response of Total nEoadjuvant Treatment of Two Methods of Long-term or Short-term cHemoRadiotherapy Followed by Consolidation Chemotherapy in Patients With Locally Advanced rectAl Cancer (TEHRAN) , a Randomized Controlled Clinical Trial
NCT05920928 is registered in ClinicalTrials.gov with Tehran University of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of the Clinical Response of Total nEoadjuvant Treatment of Two Methods of Long-term or Short-term cHemoRadiotherapy Followed by Consolidation Chemotherapy in Patients With Locally Advanced rectAl Cancer (TEHRAN) , a Randomized Controlled Clinical Trial
- Lead sponsor
- Tehran University of Medical Sciences
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- September 23, 2023
- Completion date
- April 1, 2025
- Enrollment
- 114 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
locally advanced rectal carcinoma